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Abstract
Atrioventricular (AV) endocardium transforms into the cushion mesenchyme, the primordia of the valves and membranous septa, through
epithelial–mesenchymal transformation (EMT). While bone morphogenetic protein (BMP)-2 is known to be critical for AV EMT, the role of
BMP-2 in post-EMT AV valvulogenesis remains to be elucidated. To find BMP signaling loops, we first localized Type I BMP receptors
(BMPRs), BMPR-1A (ALK3), -1B (ALK6) and ALK2 in AV cushion mesenchyme in stage-24 chick embryos. Based on the BMP receptor
expression pattern, we examined the functional roles of BMP-2 and BMP signaling in post-EMT valvulogenesis by using stage-24 AV cushion
mesenchymal cell aggregates cultured on 3D-collagen gels. Exogenous BMP-2 or constitutively active (ca) BMPR-1B (ALK6)-virus treatments
induced migration of the mesenchymal cells into the collagen gels, whereas noggin, an antagonist of BMPs, or dominant-negative (dn) BMPR-1 B
(ALK6)-virus treatments reduced cell migration from the mesenchymal cell aggregates. Exogenous BMP-2 or caBMPR-1B (ALK6) treatments
significantly promoted expression of an extracellular matrix (ECM) protein, periostin, a known valvulogenic matrix maturation mediator, at both
mRNA and protein levels, whereas periostin expression was repressed by adding noggin or dnBMPR-1B (ALK6)-virus to the culture. Moreover,
transcripts of Twist and Id1, which have been implicated in cell migration in embryogenesis and activation of the periostin promoter, were induced
by BMP-2 but repressed by noggin in cushion mesenchymal cell cultures. These data provide evidence that BMP-2 and BMP signaling induce
biological processes involved in early AV valvulogenesis, i.e. mesenchymal cell migration and expression of periostin, indicating critical roles for
BMP signaling in post-EMT AV cushion tissue maturation and differentiation.
© 2008 Elsevier Inc. All rights reserved.Keywords: Bone morphogenetic protein (BMP); Cardiac cushions; Viral gene transfer; Periostin; Extracellular matrix protein; Cell migration; Cell proliferation;
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Cardiac valvuloseptal morphogenesis is one of the key
morphogenic events during four-chambered heart formation.
Defects in valvuloseptal morphogenesis are among the most
common and serious of all congenital heart defects (Hoffman
and Kaplan, 2002; Hoffman et al., 2004). Two segments of
the endocardium–atrioventricular (AV) and outflow tract (OT)
endocardium-transform into cushion mesenchyme, primordia
of the valves and membranous septa through an epithelial–
mesenchymal transformation (EMT) (reviews, Eisenberg and
Markwald, 1995; Nakajima et al., 2000; Armstrong and⁎ Corresponding author.
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doi:10.1016/j.ydbio.2007.12.028Bischoff, 2004; Person et al., 2005). This transformation occurs
at around Hamburger and Hamilton (HH) stage (Hamburger and
Hamilton, 1951) 15 in the AV canal of the chick heart.
Transformed endocardial cells subsequently migrate into the
underlying extracellular matrix (ECM) referred to as “cardiac
jelly” and remodel the cardiac jelly into mesenchymalized
swellings, called “cardiac cushions” by HH stage 24/25. Distal
outgrowth and maturation of the cardiac cushions are the initial
and critical morphogenetic events during post-EMT valvulo-
genesis. These morphogenetic events, which begins at HH stage
26, involves i) migration of post-EMT endocardial cells into
acellular cardiac jelly; ii) proliferation of post-EMTcells and iii)
expression of valvulogenic molecules which include ECM
proteins involved in maturation of the cushion mesenchyme (de
la Cruz and Markwald, 1998; Oosthoek et al., 1998). However,
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outgrowth and maturation of post-EMT cardiac cushion mesen-
chyme are unknown.
Bone morphogenetic protein (BMP) is a member of the
TGF-β superfamily proteins, and it is one among many
molecules implicated in AV EMT (Armstrong and Bischoff,
2004; Person et al., 2005). BMP signaling was found to be
essential for AV EMT in studies with explant cultures in mice
(Sugi et al., 2004) and chicks (Okagawa et al., 2007), and in
BMP-2 conditional knockout (CKO) experiments in mice
(Ma et al., 2005; Rivera-Feliciano and Tabin, 2006). However,
BMP-2 CKO at the EMT stage causes subsequent lethality,
which prevents investigation of the role of BMP-2 during post-
EMT valvulogenesis. BMPs exert their biological function by
interacting with cell surface receptors. BMP receptors (BMPRs)
consist of Type I and Type II receptors and Type II receptors
transphosphorylate the glycine-serine rich domain (GS domain)
of Type-I receptors and transduce signals (Hogan, 1996;
Yamashita et al., 1996; de Caestecker, 2004). The Type II
BMP receptor, BMPRII is reported to be expressed ubiquitously
in the entire embryo at least up to the mid-gestation stages
(Roelen et al., 1997). Therefore, to find the potential BMP
signaling loops during post-EMT valvulogenesis, we first
explored the expression patterns of Type I BMPRs by
localizing BMPR-1A (ALK3), BMPR-1B (ALK6) and ALK2 in
the HH stage-24 post-EMT AV cushion mesenchyme in the
chick. Basing our investigation on the BMP receptor expres-
sion patterns, in this work we examined whether BMP sig-
naling regulated the biological processes necessary for distal
outgrowth and maturation of post-EMT cushion mesenchyme
during early valvulogenesis.
Periostin is a 90-kDa secreted ECM protein, related to the
midline fasciclin-1 gene in Drosophila (Horiuchi et al., 1999). It
has also been identified as a heart-enriched gene in embryonic
day (ED) 10.5 mouse embryos by a subtractive cDNA
microarray approach (Kruzynska-Frejtag et al., 2001). Periostin
is highly expressed in the maturation zone of post-EMT cardiac
cushions in mice (Kruzynska-Frejtag et al., 2001; Norris et al.,
2005) and in chicks (Norris et al., 2004; Kern et al., 2005).
Periostin is found to regulate collagen I fibrillogenesis and
contribute to the biomechanical properties of connective tissues
in skin and AV valves (Norris et al., 2007). Recent data using
chick primary culture assays demonstrated that periostin
enhanced cell invasion/migration and collagen condensation
by AV cushion mesenchyme, indicating that periostin mediates
matrix maturation, a crucial process in early valvulogenesis
(Butcher et al. 2007). Regarding the regulation of periostin
expression, periostin is known to be induced by BMP-2 in
MC3T3 cells (Ji et al., 2000) and by TGFβ-2 in primary
osteoblast cells (Horiuchi et al., 1999). BMP inducible helix–
loop–helix (HLH) proteins, Twist1 and Id1 (Valdimarsdottir
et al., 2002; Komaki et al., 2007), are implicated in regulating
the activation of the periostin promoter in osteogenesis (Oshima
et al., 2002; Connerney et al., 2006). However, little is known
about regulation of periostin expression in cardiac cushion
mesenchymal cells during post-EMT valvulogenesis. There-
fore, we have chosen periostin as a post-EMT differentiationand maturation target protein whose expression can be regulated
by BMP signaling during early AV valvulogenesis.
To study the regulation of post-EMT cushion mesenchyme
differentiation and maturation, which begins at HH stage 26
(de la Cruz and Markwald, 1998; Oosthoek et al., 1998) as
mentioned above, we developed and established a primary
culture assay system using HH stage-24 chick AV cushion
mesenchymal cell aggregates with three-dimensional (3D)
collagen gels in which we are able to evaluate i) post-EMT
mesenchymal cell migration, ii) post-EMT mesenchymal cell
proliferation and iii) post-EMT valvulogenic protein expres-
sion. Using this culture assay system, we show that BMP-2 and
BMP signaling through BMP receptors induce mesenchymal
cell migration and periostin expression at both the mRNA and
protein levels as well as Id1 and TwistmRNA expression but do
not induce proliferation of post-EMTAV cushion mesenchymal
cells.
Materials and methods
Chick embryos
Viral-free fertilized eggs of White Leghorn (Gallus gallus domesticus)
chicken were purchased from Spafas Inc. (Norwich, CT) and incubated in a
humid atmosphere at 37 °C. Stages of embryonic development were determined
by using the criteria of Hamburger and Hamilton (HH) (1951).
Detection of the Type I BMP receptor expression from HH stage-24
chick AV canal by reverse transcription-polymerase chain reaction
(RT-PCR)
HH stage-24 AV cushion mesenchyme was carefully separated from the
associated myocardium. RT-PCR analysis of BMPR-1A, BMPR-1B and ALK2
was performed as described previously (Sugi and Markwald, 2003; Okagawa
et al., 2007) with minor modifications. Briefly, total RNA was extracted and
purified from HH stage-24 AV cushion mesenchyme or myocardium using RNA
STAT-60 (Tel-Test Inc). Complementary DNA was prepared with an iScript
cDNA synthesis kit (BIO RAD) according to the manufacturer's instructions.
PCR primer pairs were designed for BMPR-1A (L49204, forward, 5′-
CTGAGAGTTGAGCGATTG-3′, reverse, 5′-CAGCCAGAAGCAAGTGTT-
GG-3′), BMPR-1B (D13432, forward, 5′-GGAGAGCAGAAAAGAAGA-
TAGTGAGG-3′, reverse, 5′-TGGTGTGGAATAGGAGTGTCC-3′) and ALK2
(U38622, forward, 5′-CTGTGTTGGGGTCACTG-3′, reverse, 5′-TGGAAG-
CAGCCTTTCTGG-3′). PCR was performed with these primer pairs and Taq
polymerase on a iCycler iQ Real-Time PCRmachine (BIO-RAD) using 30 cycles
of 94 °C for 30 s, 56 °C for 30 s and 72 °C for 2 min. That the PCR products were
not amplified from genomic DNAwas verified by treating samples with RNase-
free DNase-1 (Stratagene) before RT. As a negative control, the RT step was
omitted. The PCR products were verified via the thermal cycle sequencing using
TagDNA polymerase and fluorescent dye-labeled termination (Medical Uni-
versity of South Carolina (MUSC), Biotechnology Resources Laboratory).
Whole-mount and section in situ hybridization (ISH) for BMP
receptors
HH stage-25 chick heart RNAwas isolated using RNeasy Column (Qiagen)
and reverse-transcribed into cDNA (Stratagene) (Norris et al., 2004). For whole-
mount ISH, a 200–250 bp sequence was used for better penetration and rinsing
of the probes to reduce the background binding. The following sequences were
amplified for type I BMP receptors using HH stage-25 chick heart cDNA:
BMPR-1A (L49204; nt 351–640), BMPR-1B (D13432; nt 387–720) and
ALK2 (U38622; nt 21–299) for the whole mount ISH probes. For section ISH,
longer sequences were used for the better detection of the mRNA expression for
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Amplified sequences were verified by sequencing (MUSC, Biotechnology
Resources Laboratory). Database sequence homology searches confirmed that
the sequences for BMPR-1A, BMPR-1B and ALK-2 used in the ISH are not
anticipated to cross-react with other family members and are highly specific.
Riboprobes were generated by DIG RNA labeling (SP6/T7, Roche). Riboprobes
were purified by RNeasy column (Qiagen) and quantified using a UV spectro-
photometer. ISH was performed as previously described with slight modifica-
tions (Norris et al., 2004; Somi et al., 2004). ISH experiments were carried out
on stage-24 chick embryos. A specific signal was only observed when whole
hearts or sections were hybridized with the antisense riboprobe. No signal was
detected when using the control sense riboprobe (Fig. 1).
Generation and preparation of retrovirus
Two mutant constructs of chick BMPR-1B cloned into the replication-
competent avian retroviral vector RCAS-(A) (Hughes et al., 1987) were kindlyFig. 1. (A) RT-PCR analysis revealed mRNA expression of type I BMP receptors i
cushion mesenchyme and myocardium. ALK2 was detected in the AV cushion me
(B) Whole-mount in situ hybridization revealed mRNA expression of Type I BMP
found in the AVand OT cushion mesenchyme and in the myocardium. ALK2 was loc
not in the myocardium (arrows show endocardium). Lower levels of BMPR-1B
hybridization revealed BMPR-1A expression in the AV and OT endocardium and cu
(arrows) in the HH stage-24 chick heart. Intense expression of ALK2was detected in th
Low levels of BMPR-1B expression were detected ubiquitously in stage-24 whole hprovided by Dr. L. Niswander. The dominant-negative form (dnBMPR-1B)
blocks BMP signaling pathways by a single amino acid substitution (Lys-231 to
Arg) within the adenosine triphosphate binding site in the kinase domain.
Because dnBMPR-1B lacks the activity of an intracellular kinase domain,
dnBMPR-1B expressed at the cell surface can bind BMPs but does not transmit
signals. The constitutively active form (caBMPR-1B) has a single amino acid
substitution (Gln-203 to Asp) within the GS activation domain. caBMPR-1B is
activated constitutively and transmits signals without BMP binding. dnBMPR-
1B and caBMPR-1B viruses were previously constructed and verified in avian
embryonic tissue culture as being capable of blocking and activating BMP
signaling, respectively (Zou and Niswander, 1996; Zou et al., 1997).
Primary fibroblasts were collected from day-10 chick embryos and
transfected with retroviral constructs using FuGENE 6-transfection reagent
(Roche). Supernatant from the transfected cultures was collected and
concentrated by ultracentrifugation. Concentrated virus was resuspended in
M199 medium (Invitrogen) and stored at −80 °C. The viral titer was measured
with immunohistochemical detection of viral protein p19 with monoclonaln HH stage-24 chick AV canal. BMPR-1A and BMPR-1B were detected in AV
senchyme; however, little ALK2 expression was seen in the AV myocardium.
receptors in HHstage-24 chick AV hearts. Abundant BMPR1A expression was
alized in the AVand OT cushion mesenchyme and ventricular endocardium but
expression were detected in HH stage-24 whole hearts. (C) Section in situ
shion mesenchyme. BMPR-1A expression was also detected in the myocardium
e AVand OTendocardium and cushion mesenchyme but not in the myocardium.
earts. No specific binding was detected with the sense probes.
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infected chick fibroblast cultures. Aviral titer (2×109 to 5×1010 active viron/ml)
was routinely achieved after ultracentrifugation of the viral supernatant.
AV cushion mesenchymal cell aggregate culture
AV cushion mesenchyme was dissected out from HH stage-24 chick AV
cushions by carefully removing the associated myocardium. Cushion mesench-
yme was dispersed by trypsinization as described previously (Sugi et al., 2003).
Following the procedure that was described for culturing cell aggregates from
chick blastoderm (Eisenberg and Markwald, 1997), 40,000 cells were cultured
as a hanging drop in 20 μl of serum-free medium 199 (Invitrogen) supplemented
with ITS (5 μg/ml insulin, 5 μg/ml transferrin and 5 ng/ml selenium, BD
Sciences) and antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin,
Invitrogen) overnight. Resultant mesenchymal cell aggregates were placed on
hydrated collagen gels (1 mg/ml, rat tail tendon, BD Sciences) and cultured with
medium 199 supplemented with 1% chick serum (Sigma), ITS and antibiotics as
described above. Two hours later, recombinant human BMP-2 (kindly provided
by the Genetics Institute, Cambridge, MA) at final concentrations ranging from
20 to 200 ng/ml, recombinant human noggin (kindly provided by Regeneron
Pharmaceuticals) at final concentration of 500 ng/ml or dnBMPR1B- or
caBMPR1B-RCAS-virus (final concentration, 1.5×108 active viron/ml) was
added alone or in combination with BMP-2 to the culture. Cultures were
observed daily under an inverted microscope with Hoffman optics (Olympus,
IMT-2). Cell migration, expression of periostin protein and mRNA, and cell
proliferation were evaluated at 72 h.
Cell migration assay
Seventy-two hours after placing the AV cushion mesenchymal cell
aggregates on collagen gels, cell migration was assessed under an inverted
microscope with Hoffman optics (Olympus, IMT-2). Cell numbers were counted
in a series of focal planes from the surface to the bottom of the collagen gels at
40 μm intervals.
BrdU incorporation assay
BrdU incorporation was used as an index of cell proliferation. The BrdU
incorporation assay for cushion mesenchymal cells was performed as previously
described (Sugi et al., 2003). Briefly, BrdU was added (final con-
centration=50 μM) for 2 h before the termination of the culture. After rinsing
with phosphate buffered saline (PBS), pH. 7.4, cultured cushion mesenchymal
cells were incubated in 2N HCl containing 0.5% Tween20 and processed for
immunohistochemical detection of BrdU in the nuclei with anti-BrdU (BD
Sciences). All nuclei were stained with propidium iodide. Stained samples were
observed under a Leica TCS SP2 AOMS confocal microscope.
Immunostaining and immunointensity analysis
Immunostaining and immunointensity analysis for cushionmesenchymal cell
aggregates cultured on collagen gels were performed as described before (Sugi
et al., 2004) with minor modifications. Briefly, cultured cushion mesenchymal
cell aggregates were fixed in 100% methanol at 20 °C and processed for
immunostaining with anti-phospho-Smad1/5/8 (Cell signaling), anti-chick
periostin, or an RCAS virus marker (AMV3c2, Hybridoma Bank) depending
on the experimental necessity. Anti-chick periostin antibodies were produced
against a peptide corresponding to amino acids 122–140 of chick periostin and
characterized byWestern analysis and immunohistochemistry (Kern et al., 2005).
Immunostained samples were observed under a confocal microscope (Leica TCS
SP2 AOBS). The immunointensity of periostin and AMV3c2 were evaluated
by measuring the intensity of the immunofluorescence of the cell aggregates
on photographs using computer software, Adobe Photoshop 8.0.
Quantitative RT-PCR for periostin, Id1 and Twist
Total RNA was extracted and purified using RNA STAT-60 (Tel-Test Inc)
from cushion mesenchymal-cell aggregates that had been cultured for 72 h onthe collagen gels. Obtained mRNA was further purified by PicoPure RNA
Isolation kit (Arcturus). Complementary DNAwas prepared using the iScript™
cDNA synthesis kit (BIO RAD) according to the manufacturer's instruction.
The following PCR primer pairs were designed to specifically amplify chick
periostin (AY65700, Forward, 5′-TCGGTGGAAAACTGCTAAGAG-3′;
Reverse 5′-TCTGCTGGCTTGATGATTTG-3′), chick Id1 (AY040527,
Forward 5′-CTCCCAACTCCACTTTCCAG-3′; Reverse 5′AGCGGCGAC-
CAATAGCAG-3′), chick Twist (AY126449, Forward, 5′-GGGATAGGGGT-
GTGTGTGTG-3′; Reverse 5′-GAGAGGAGGGACTTTTGCTG-3′). Real-
time PCR reactions were performed using 50 cycles of 94 °C for 30 s, 56 °C
for 30 s and 72 °C for 2 min. Chick periostin amplification was normalized to
chick β-actin amplification for each experimental treatment. QRT-PCR results
represent at least three independent experiments with reactions performed in
triplicate.
Statistical analyses
Analysis of variance (ANOVA) was used to determine significant
differences between groups. When differences were found among groups, the
Turkey–Kramer's t-test was used to determine if the difference was statistically
significant. Differences were considered significant if pb0.05.
Results
mRNA expression of type I BMP receptors by HH stage-24
chick AV canal
RT-PCR analysis revealed mRNA expression of BMPR-1A
and BMPR-1B in both AV cushion mesenchyme and myocar-
dium from HH stage-24 chick embryos (Fig. 1A). ALK2 was
detected in the AV cushion mesenchyme; however, ALK2
expression was not detectable in the myocardium (Fig. 1A).
By whole-mount ISH BMPR-1A was localized in the AV
and OT cushion mesenchyme from HH stage 24 chick
embryos. BMPR-1A expression was also detected in the
myocardium by whole mount (Fig. 1B, cBMPR1A) and by
section ISH (arrows in Fig. 1C, R1A). ALK2 was localized in
the AV and OT endocardium and cushion mesenchyme (Fig.
1B and arrows Fig. 1C, ALK2) and in the ventricular endo-
cardium (arrows in Fig. 1B, cALK2) but not in the myo-
cardium. A lower level of BMPR-1B expression was detected
ubiquitously by the HH stage-24 whole hearts (Fig. 1B,
cBMPR1B) and in the sections from HH stage-24 chick
embryos (Fig. 1C, R1B). Sense probes used as negative con-
trols for the ISH did not produce any detectable signals (sense
panels in Figs. 1B and C).
Development of AV cushion mesenchymal cell aggregate
culture
To study the regulation of post-EMT cushion mesenchyme
maturation and differentiation, we developed a primary culture
assay system, in which we were able to evaluate post-EMT
mesenchymal cell migration, cell proliferation and post-EMT
valvulogenic protein expression. This culture assay system was
developed using dissociated HH stage-24 chick AV cushion
mesenchymal cells. Cushion mesenchymal cells were cultured
as a hanging drop overnight with serum-free medium. Resultant
mesenchymal cell aggregates were cultured on the surface of 3D
collagen gels with 1% chick serum and observed daily for 72 h
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that the mesenchymal cells are initially trypsinized and possess
minimal ECM proteins before BMP or virus treatments are
initiated (Fig. 2A), and that the original cell number is easily
quantified for subsequent monitoring in response to BMP
signaling.
BMP-2 induces AV cushion mesenchymal cell migration
AV cushion mesenchymal cells treated with BMP-2
(200 ng/ml) migrated deeper into the collagen gels (Fig. 2,
arrowheads in I) than the control (Fig. 2, arrowheads in H).
Effects of BMP-2 were abolished when noggin (500 ng/ml)
was added to the BMP-2-containing medium (Fig. 2J). Noggin
alone with the Medium 199 also repressed migration of
cushion mesenchymal cells (Fig. 2K). No significant differ-
ences were seen in surface migration area between treatments
(data not shown). Quantitative analysis indicated the dose-
dependent effects of BMP-2 in mesenchymal cell migration
into collagen gels (Fig. 3). As indicated in Fig. 3A, as little as
50 ng/ml of BMP-2 significantly promoted mesenchymal cell
migration. BMP-2-promoted cell migration was abolished by
adding noggin to the BMP-2-treated mesenchymal cell culture
(Fig. 3B). Moreover, the endogenous level of mesenchymal
cell migration was repressed in cultures treated with noggin
alone compared to the control (Fig. 3B). These results indicateFig. 2. (A–C) Representative pictures from cultured AV cushion mesenchymal cell a
on collagen gels with control M199 medium. AV cushion mesenchymal cells from H
mesenchymal cell aggregates were placed on collagen gels and cultured for an addit
aggregate culture. Upper panels show the surface view, and lower panels show a dee
with BMP-2 (200 ng/ml) migrated deeper into the collagen gels (arrowheads in
mesenchymal cell migration was abolished when noggin (500 ng/ml) was added to
below the level of control Medium 199 treatments (G and K).that BMP-2 induces cell migration by cultured AV cushion
mesenchymal cells.
BMP treatment enhances phospho-Smad 1/5/8 expression in
cushion mesenchymal cells
To test whether exogenous BMP-2 treatment induces
intracellular BMP signaling in cultured AV cushion mesen-
chymal cells, activation of Smad 1/5/8 phosphorylation was
examined by detecting phospho-Smad 1/5/8 expression. AV
cushion mesenchymal cells treated with BMP-2 (200 ng/ml)
and cultured on collagen gels showed significantly elevated
phospho-Smad 1/5/8 expression (Figs. 4B and D). Noggin
treatment repressed endogenous phopho-Smad1/5/8 expression
in the AV cushion mesenchymal cells compared to control
culture (Figs. 4C and D). These results indicate that BMP-2
treatment activates intracellular BMP signaling in cultured AV
cushion mesenchymal cells.
BMP-2 does not stimulate mesenchymal cell proliferation
To determine whether BMP-2 regulates AV cushion
mesenchymal cell proliferation, we assessed BrdU incorpora-
tion as an index of cell proliferation in AV cushion
mesenchymal cells. Neither exogenously added BMP-2 nor
noggin treatment altered the BrdU incorporation by AV cushionggregates. These pictures show how cushion mesenchymal cell aggregates grow
H stage-24 chick embryos were cultured as a hanging drop overnight. Resultant
ional 72 h. (D–K) Higher magnification view of AV cushion mesenchymal cell
per view in collagen gels (240 μm from the surface). Mesenchymal cells treated
panel I) than the control culture (arrowheads in panel H). BMP-2-promoted
the medium (F and J). Noggin treatments reduced mesenchymal cell migration
Fig. 3. Quantitative evaluation of cell migration by HH stage-24 AV cushion
mesenchymal cell aggregate culture. A: BMP-2 (as low as 50 ng/ml) promoted
cell migration (⁎pb0.001). B: BMP-2-promoted cell migration was abolished
by adding noggin (500 ng/ml) to the mesenchymal cell-aggregates culture
(⁎pb0.001). Mesenchymal cell migration was reduced in cultures treated with
noggin alone or noggin with BMP-2 compared to the control (⁎⁎pb0.05).
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treatment (Supplemental Figs. 1A–H and I). These results
indicate that BMP-2 does not alter the proliferation ratio of HH
stage-24 post-EMT AV cushion mesenchymal cells.
BMP-2 treatment increases periostin expression by AV cushion
mesenchymal cells
Periostin expression (mRNA and protein) was assessed in
AV cushion mesenchymal cell aggregates cultured on collagen
gels. Periostin protein expression was analyzed by immunos-
taining (Figs. 5A–F) and quantitatively evaluated by immu-
nointensity (Fig. 5G). Periostin expression in AV cushion
mesenchymal cell aggregates was elevated when treated with
BMP-2 (Figs. 5B–D). Significant promotion of periostin protein
expression was detected when AV cushion mesenchymal cell
aggregates were treated with as little as 20 ng/ml BMP-2
(Fig. 5G). Noggin treatments inhibited BMP-2-supported
induction of periostin expression (Figs. 5E and G). Treat-
ments with noggin alone with Medium 199 also significantlyrepressed endogenous periostin expression by cultured AV
cushion mesenchymal cell aggregates as compared to the
control treatment (Figs. 5F and G).
Periostin mRNA expression was assessed with quantitative
(Q) RT-PCR with AV cushion mesenchymal cell aggregates
cultured on collagen gels (Fig. 5H). QRT-PCR data revealed an
approximately 3-fold increase of periostin expression by AV
cushion mesenchymal cell aggregates treated with BMP-2 over
the control treatments with Medium199 (Fig. 5H). As low as
20 ng/ml of BMP-2 induced periostin expression (Fig. 5H).
BMP-2-supported elevation of periostinmRNA expression was
abolished when noggin was added to the culture. Noggin alone
with Medium 199 also significantly repressed endogenous
periostin mRNA expression by cultured AV cushion mesench-
ymal cell aggregates.
BMP-2 treatment increases Id1 and Twist expression by AV
cushion mesenchymal cells
In our present work, RT-PCR analysis revealed endogenous
expression of chick Id1 and Twist in HH stage-24 chick AV
canal. Id1 and Twist were detected in the AV cushion
mesenchyme but not clearly detected in the myocardium (Fig.
6A). Chick Twist has been localized in HH stage 22–30 chick
AV cushion mesenchyme by in situ hybridization (Dr. R.
Heimark, University of Arizona; personal communication). To
test whether BMP signaling regulates expression of these
transcription factors, chick Twist and Id1 mRNA expression
was assessed with QRT-PCR with AV cushion mesenchymal
cell aggregates cultured on collagen gels (Figs. 6B and C). QRT-
PCR data revealed an approximately 8-fold increase of both
Twist and Id1 expression by AV cushion mesenchymal cell
aggregates treated with BMP-2 over the control treatments with
Medium199. BMP-2-supported elevation of Twist and Id1
mRNA expression was abolished when noggin was added to the
culture. Noggin alone with Medium 199 also significantly
repressed endogenous Id1 and Twist mRNA expression by
cultured AV cushion mesenchymal cell aggregates.
Modulation of BMP signaling by dn- or caBMPR virus
treatments is associated with alteration of cell migration and
periostin expression by cultured AV cushion mesenchymal cells
To examine whether BMP signaling through BMP receptors
which are expressed by the AV cushion mesenchymal cells
regulates mesenchymal cell migration and periostin expression,
dn- and caBMPR-1B-RCAS-virus were applied to AV cushion
mesenchymal cell aggregates cultured on collagen gels. First,
we tested whether dn- or caBMPR-1B virus infection altered
intracellular BMP signaling in AV cushion mesenchymal cells.
AV cushion mesenchymal cell aggregates treated with dn- and
caBMPR-1B virus were examined for activation of Smad 1/5/
8 phosphorylation, a down stream effector of BMP signaling, by
immunohistochemical detection of phospho-Smad 1/5/8
expression and a viral marker, AMV3c2 staining. caBMPR-
1B-infected, AMV3c2-positive, cushion mesenchymal cells
showed elevated phospho-Smad 1/5/8-expression (arrowheads
Fig. 4. (A–C) Phospho-Smad 1/5/8 expression was detected in cultured AV cushion mesenchymal cells. BMP-2 treated mesenchymal cells showed more phopho-
Smad1/5/8 immunostaining (B) than control Medium 199 treated cushion mesenchymal cells (A). Noggin treatments reduced phospho-Smad 1/5/8 staining in the cells
(C). (D) Quantitative evaluation of phospho-smad1/5/8 immunostaining revealed that cushion mesenchymal cells treated with BMP-2 expressed elevated phopho-
Smad1/5/8 staining (pb0.01), while noggin treatments significantly reduced phospho-Smad1/5/8 staining (D).
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AMV3c2-positive, cushion mesenchymal cells repressed endo-
genous nuclear staining of phospho-Smad 1/5/8 (arrowhead in
Figs. 7B and F) as compared to the control (Figs. 7A and E).
When BMP-2 was added to dnBMPR-1B infected cushion
mesenchymal cells, a significant reduction of Smad 1/5/8 ex-
pression was also observed (Figs. 7C and G). These data
indicate that infection of dnBMPR-1B or caBMPR-1B inhibits
or enhances cytoplasmic BMP signaling respectively, in AV
cushion mesenchymal cells.
AV cushion mesenchymal cells treated with dnBMPR-1B
or caBMPR-1B virus were evaluated for cell migration. AV
cushion mesenchymal cells treated with caBMPR-1B virus
migrated deeper into the collagen gels than the mesenchymal
cells cultured with the control Medium199 (Fig. 8). Conversely,
dnBMPR1B-virus treatments significantly reduced AV cushion
mesenchymal cell migration compared to the control culture
(Fig. 8). dnBMPR-1B-treated culture had the same level of
reduction in cell migration as observed in noggin-treated
cushion mesenchymal cell culture (Fig. 3).
caBMPR1B-virus infection, as detected by a viral marker,
AMB3c2 expression, significantly increased periostin protein
expression (Figs. 9C and F) whereas dnBMPR-1B-virus
infection repressed endogenous periostin protein immuno-
staining (Figs. 9B and E) in the cushion mesenchymal–cell
aggregate culture. A higher magnification view showed that
cytoplasmic periostin expression in cushion mesenchymal cells
was elevated in caBMPR-1B-infected cells (Figs. 9I and L),
whereas periostin expression was reduced in dnBMPR-1B-infected cells (Figs. 9H and L). Quantitative evaluation by
analyzing periostin immunointensity showed significant differ-
ences among the treatments (Fig. 9M). These data indicate that
BMP signaling through the BMP receptors modulate mesench-
ymal cell migration and periostin expression by AV cushion
mesenchymal cell cultures.
In summary, we provide the evidence that BMP-2 and BMP
signaling induce cell migration and expression of a valvulo-
genic ECM protein, periostin but do not induce cell proliferation
by post-EMT AV cushion mesenchymal cells. This evidence
was demonstrated by two independent approaches of promoting
BMP signaling by gain-of-function experiments: exogenous
BMP-2 treatments and activation of BMP receptors by
caBMPR-1B-virus infection in post-EMTcushion mesenchymal
cells. The effect of BMPs in post-EMT valvulogenesis was
further determined by two independent ways of blocking BMP
signaling by loss-of-function experiments: exogenous noggin
treatment and inhibition of BMP signaling by perturbing the
BMP receptors with dnBMPR-1B-virus in post-EMT AV
cushion mesenchymal cells. These results are summarized in
a diagram, Fig. 10.
Discussion
Although accumulated data support the importance of BMPs
and BMP signaling in valvuloseptal morphogenesis (Galvin
et al., 2000; Delot et al., 2003; Kim et al., 2001; Gaussin et al.,
2002; Gaussin et al., 2005; Jiao et al., 2003; Wang et al., 2005),
the cell types that are involved and the regulatory mechanisms
Fig. 5. (A–F) Periostin immunostaining in AV cushion mesenchymal cell aggregate culture. The mesenchymal cells were cultured with control medium 199 (A), BMP-
2, 20 ng/ml (B), BMP-2, 50 ng/ml (C), BMP-2, 200 ng/ml (D), BMP-2 200 ng/ml plus noggin, 500 ng/ml (E) or noggin, 500 ng/ml (F). As low as 20 ng/ml of BMP-2
promoted periostin immunostaining by cultured cushion mesenchymal cell aggregates. (G) Quantitative evaluation of periostin immunostaining in AV cushion
mesenchymal cell aggregate culture. Immunointensity of the mesenchymal cell aggregates treated with as little as 20 ng/ml of BMP-2 was significantly higher than the
control (⁎pb0.01). Conversely, immunointensity in mesenchymal cell aggregates cultured with noggin was significantly lower than the control (⁎⁎pb0.05).
(H) Quantitative evaluation of periostinmRNA expression in AV cushions mesenchymal cell aggregate culture. Real-time PCR data revealed an approximately 3-fold
increase of periostin expression in AV cushion mesenchymal cell aggregate culture treated with BMP-2 over the culture treated with control Medium199 (⁎pb0.01).
BMP-2-supported elevation of periostin expression was abolished when noggin was added to the culture (⁎⁎pb0.05).
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determined. Recent studies with Nkx2.5-cre/BMP-2 CKO
mice showed that myocardially-derived BMP-2 was essential
for AV EMT (Ma et al., 2005; Rivera-Feliciano and Tabin,
2006). Moreover, data from Tie1-cre/ALK3 and FLK1-cre/
ALK3 CKO mice indicated critical roles of ALK3 in endothelial
cells for AV EMT (Park et al., 2006; Song et al., 2007).
However, subsequent lethality of the CKO embryos after the
EMT stage prevented analysis of the role of BMP signaling in
post-EMT valvulogenesis. Although myocardial expression of
BMP-2 is down regulated in the AV canal after EMT, BMP-2 is
localized in AV cushion mesenchyme during post-EMT
valvulogenesis in chicks (Lincoln et al., 2004) and mice (Sugi
et al., 2004), suggesting potential autocrine signaling by BMP-2
in cushion mesenchymal cells during post-EMT valvulogenesis.
Therefore, in this work we sought to determine the roles of
BMP-2 and BMP signaling in post-EMT AV cushion
mesenchymal cells by using spatio-temporal viral-gene-transfer
technique with chick AV cushion mesenchymal cell cultures.
Recent work by Lincoln et al. (2006a) demonstrated that BMP-
2 induced aggrecan and sox9–which are characteristics of
cartilage cells–in AV cushion mesenchymal cells. This suggests
the existence of active BMP signaling in cushion mesenchymal
cells. As the first step of our present study, we showed theexpression of Type I BMP receptors, BMPR-1A, BMPR-1B and
ALK2, as supportive evidence for the presence of BMP
signaling in cushion mesenchymal cells and further demon-
strated that BMP-2 and BMP signaling through BMP receptors
induce mesenchymal cell migration and expression of periostin,
both of which were crucial for maturation and differentiation of
post-EMT AV cushion mesenchyme. Therefore, our current
study supports the idea that the autocrine signaling by BMPs in
cushion mesenchymal cells can regulate post-EMTAV cushion
mesenchymal cell differentiation.
Most BMP receptors have ligand binding affinity with other
TGFβ superfamily proteins, i.e. TGFβ and activin. However,
BMPR-1A and BMPR-1B bind specifically with BMP-2 and
BMP-4, and bind with BMP-7 at low affinity but do not bind
with TGFβs or activin (Dijke et al., 1994; Raftery and
Sutherland, 1999; de Caestecker, 2004). In this work, we
demonstrated that dnBMPR-1B infection as well as treatments
with a BMP antagonist, noggin, significantly repressed endo-
genous phospho-Smad 1/5/8 expression in AV cushion mesen-
chymal cells, which indicated that intracellular BMP signaling
in the cushion mesenchymal cells was effectively inhibited
by the treatments with dnBMPR-1B or noggin. Conversely,
BMP-2 or caBMPR-1B-virus treatments induced expression of
phospho-Smad 1/5/8, indicating that intracellular BMP
Fig. 6. (A) RT-PCR analysis revealed mRNA expression of chick Id1 and Twist
in HH stage-24 chick AV canal. Id1 and Twist were detected in AV cushion
mesenchyme but not detectable in myocardium. (B and C) Quantitative
evaluation of chick Id1 and Twist mRNA expression in AV cushions
mesenchymal cell aggregate culture. Real-time PCR data revealed an
approximately 8-fold increase in expression of both Twist (B) and Id1 (C) in
AV cushion mesenchymal cell aggregate culture treated with BMP-2 over the
culture treated with control Medium199 (⁎pb0.01). BMP-2-supported elevation
of Twist and Id1 expression was abolished when noggin was added to the culture
(⁎pb0.01).
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Although BMPR-1B does not appear to be the most prominent
Type 1 BMP receptor expressed in the AV canal (Fig. 1), our
data indicated that overexpression of dnBMPR-B1or caBMPR-
1B evidently modulated intracellular BMP signaling in the AV
cushion mesenchymal cells. For example, dnBMPR-1B treat-
ments inhibited BMP-2-supported up-regulation of cell migra-
tion as well as phospho-Smad1/5/8 expression in the cushion
mesenchymal cells. The effects of dnBMPR-1B treatments on
cushion mesenchymal cell migration and phospho-Smad1/5/8
expression are as profound as noggin treatments (Figs. 7 and 8).
Because noggin is expected to antagonize BMP signaling
through any Type I BMP receptors, the present data stronglysuggest that the excess dominant negative forms of BMPR-1B
are potentially disrupting BMP signaling by competing with
other endogenously expressed Type I BMP receptors, i. e.
BMPR-1A and/or Alk2. dnBMPR-1B and caBMPR-1B appear
to function as broader reagents that can inhibit or activate BMP
signaling through Type I BMP receptors in our AV cushion
mesenchymal cell cultures. Therefore, our data do not resolve
the specific biological function of BMPR-1B; however, the
present study using AV cushion mesenchymal cells provides an
example that the dominant-negative and constitutively active
approach can be a powerful tool to effectively modulate BMP
signaling when multiple Type I BMP receptors may cause
functional redundancies.
Cell proliferation is the one of the critical biological
processes in elongation and expansion of post-EMTAV cushion
tissues in early valvulogenesis (de la Cruz and Markwald,
1998). Recent studies in cardiac valvulogenesis demonstrated
that cell proliferation in cushion mesenchyme was high at early
stages of valvulogenesis, but significantly decreased after
remodeling stages in mice (Hinton et al., 2006) and chicks
(Lincoln et al., 2004) and persisted at low levels in juvenile
mice (Hinton et al., 2006). Our previous work revealed that
fibroblast growth factor 4 (FGF4) induced cell proliferation in
HH stage-24 post-EMT AV cushion mesenchyme in vitro and
in vivo (ovo) (Sugi et al., 2003). In the present study, we
found that BMP-2 and BMP signaling did not enhance
mesenchymal cell proliferation in HH stage-24 AV cushion
mesenchymal cell culture. BMP-2 is shown to induce Tbx20
that induces cell proliferation but represses expression of an
ECM proteoglycan, aggrecan (Shelton and Yutzey, 2007).
However, BMP-2 is also reported to induce aggrecan expres-
sion from cultured HH stage-25 AV cushion mesenchymal
explants (Lincoln et al., 2006a). Tbx20 may exert positive (Cai
et al., 2005) or negative feedback (Singh et al., 2005) on BMP-2
expression. Moreover, resent studies on deletion of noggin,
which is an antagonist of BMPs and is expressed in both AV
myocardium and cushion mesenchyme, showed that prolifera-
tion was increased in the myocardium but not in the cushion
mesenchyme, suggesting tissue specific responses of BMP
signaling (Choi et al., 2007). Therefore, precise signaling
mechanisms and molecular interactions of BMP signaling
governing cell proliferation in cushion mesenchyme are not
fully understood. Taken together, our present study demon-
strates that unlike FGF4 or Tbx20, BMP-2 is not responsible for
a high proliferation ratio in endocardial cushions during early
valvulogenesis but may be a key regulator in other necessary
morphological processes in early valvulogenesis, i.e. produc-
tion of valvulogenic ECM protein such as periostin and
induction of cell migration.
Valvulogenesis is thought to be regulated by a complex
coordination of growth factor signaling and ECM interactions
(Camenisch et al., 2002; Schroeder et al., 2003); however, these
processes have not fully elucidated. In the cardiac cushion,
periostin expression is observed only after the EMT (Kern et al.,
2005) and is closely correlated with the morphogenic processes
associated with differentiation of cardiac cushion mesenchyme
into dense, fibrous tissues and is proposed to be responsible for
Fig. 7. Phospho-Smad 1/5/8 immunostaining. Mesenchymal cells infected with dnBMPR-1B-virus, as seen as AMV3c2 positive cells (B and F) showed less
phospho-Smad1/5/8 staining (an arrowhead in panel F) than the control cells (A and E). Mesenchymal cells infected with dnBMPR-1B-virus and treated with BMP-2
(200 ng/ml) (C and G) also showed less phospho-Smad1/5/8 staining (arrowheads in panel G) than the control cells (A and E). Mesenchymal cells treated with
caBMPR-1B-virus (D and H) showed more intense phopho-Smad1/5/8 staining (arrowheads in panel H). Panels A–D were stained for, a viral marker, AMV3c2
(green). Panels E–H were stained for phopho-Smad1/5/8 (red).
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the AV valvular suspensory apparatus (Markwald et al., 2004;
Litvin et al., 2005). Periostin is also proposed to potentially
regulate differentiation and recruitment of circulating adult bone
marrow cells into postnatal hearts (Visconti and Markwald,
2006). Moreover, recent data in post-EMT valvulogenesis using
chick primary culture assays indicated that periostin enhanced
cell invasion/migration and collagen condensation by cushion
mesenchyme which highlighted periostin as a mediator of
matrix maturation and remodeling (Butcher et al., 2007). There-
fore, periostin is proposed to promote and sustain differentiationFig. 8. Quantitative evaluation of cell migration by AV cushion mesenchymal
cells treated with dnBMPR-1B-virus or caBMPR-1B-virus. Mesenchymal cells
treated with caBMPR-1B-virus migrated significantly deeper into the gels than
the control (⁎pb0.01) similar to the level seen in BMP-2-treated mesenchymal
cells. Conversely, BMP-2-supported up-regulation of cell migration was sig-
nificantly reduced by dnBMPR-1B treatments (⁎⁎pb0.05).of cushion mesenchyme into fibrous connective tissues and is a
central player in cushion differentiation and maturation.
Although periostin deficient mice do not show early lethality
that could be attributed to serious defects in early valvulogen-
esis (Kii et al., 2006; Rios et al., 2005; Norris et al., 2007), this
could be explained by molecular redundancies with a closely
related molecule, bigH3, which is in the same gene family and is
co-expressed with periostin in developing valvular tissues
(Norris et al., 2004). Our present work also demonstrates a
striking increase in chick Twist and Id1 expression in cushion
mesenchymal cells cultured with BMP-2. Twist1, a member of
the bHLH family protein, can specifically bind to the putative
binding site, the Twist-box, on the periostin promoter in vitro in
osteoblast MC3T3 cells (Oshima et al., 2002). It has also been
determined by using Twist1 over-expressing 293 T cells that
Twist up-regulates mouse periostin transcription (Oshima et al.,
2002). Id1 protein, a Class II HLH protein that lack the basics
domain which is required for DNA-binding (Benezra et al.,
1990), preferentially dimerizes with E proteins and, hence,
enhances Twist homodimer formation (Connerney et al., 2006).
Critical evidence generated using in C3H10T1/2 mesenchymal
cells is that overexpressing Twist1 homodimers enhances
periostin expression, whereas expression of Twist 1 heterodimer
inhibits it (Connerney et al., 2006). Therefore, an increase in the
transcripts of the chick homologue of Twist1 and Id1 by BMP
signaling in our experiments can be associated with activation
of the periostin promoter in AV cushion mesenchymal cells.
Collectively, our present work provides initial evidence that
BMP-2 and BMP signaling induce periostin expression in post-
EMT AV cushion mesenchymal cells.
Other than the inductive roles for periostin promoter
activation, Id1 and Twist have been known to regulate various
aspects of embryonic development including cell migration as
Fig. 9. (A–F) Periostin Immunostaining in AV cushion mesenchymal cell aggregate culture. Mesenchymal cell aggregates treated with dnBMPR-1B-virus (B and E)
resulted in a significant decrease in periostin immunostaining compared to the no-virus control (A and D). Infection with caBMPR-1B-virus significantly increased
periostin expression in AV mesenchymal cell culture (C and F). Upper panel (A–C), a viral marker, AMV3c2 immunostaining (green). Lower panel (D–F), periostin
immunostaining (red). (G–L) Higher magnification view of RCAS-virus-infected AV cushion mesenchymal cells. Cells infected with dnBMPR-1B-virus showed less
periostin staining (an arrow in panel K) than no-virus infected cells (arrow in panel J). Cells infected with caBMPR-1B showed more intense periostin staining (arrows
in panel L) than no-virus control (an arrow in panel J). Upper panel (G–I), viral marker AMV3c2 immunostaining (green). Lower panel (J–L), periostin
immunostaining (red). (M) Quantitative evaluation of periostin immunostaining in AV cushion mesenchymal cell aggregates treated with dn- and caBMPR-1B-virus.
Immunointensity of the mesenchymal cell aggregates treated with caBMPR-1B was significantly higher than the control (⁎pb0.01). Conversely, immunointensity in
mesenchymal cell aggregates infected with dnBMPR-1B was significantly lower than the control (⁎pb0.01).
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Fig. 10. Summary diagram illustrating the results from bioassays to assess the role of BMP-2 and BMP signaling using AV cushion mesenchymal cell aggregates
cultured on 3D-collagen gels. Results were evaluated 72 h after placing the aggregates on the collagen gels. Exogenous BMP-2 or caBMPR-1B treatments induced
mesenchymal cell migration and expression of periostin, Twist and Id1, while a BMP antagonist, noggin, or dnBMPR-1B treatment inhibited BMP-2 promoted cell
migration and expression of periostin, Twist and Id1. Phospho-Smad 1/5/8 expression was induced by BMP-2 or caBMPR1-B treatments but reduced by noggin or
dnBMPR-1B treatments. There was no significant difference in proliferation among treatments.
394 K. Inai et al. / Developmental Biology 315 (2008) 383–396well as tumor metastasis (Israel et al., 1999; Norton, 2000;
Ruzinova and Benezra, 2003; Kang and Massague, 2004; Yang
et al., 2004; Reinhold et al., 2006; Alexander et al., 2006;
Komaki et al., 2007). Particularly relevant to the present study is
the recent observation that Id1 and Twist1 are disrupted in AV
endocardium in Nkx2.5-cre/BMP-2 CKO mice (Ma et al., 2005;
Rivera-Feliciano and Tabin, 2006) as well as in FLK1-cre/ALK3
CKO mice (Park et al., 2006). These findings indicate that
expression of Id1 and Twist1 are regulated by BMP-2 and/or
BMP signaling in AV endocardial cells and suggest the roles of
Id1 and Twist1 in AV EMT in mice. Furthermore, Id1 is known
to play a critical role in mediating BMP-induced endothelial cell
migration by mouse embryonic endothelial cells in vitro
(Valdimarsdottir et al., 2002). Chick homologues of Ids (Id1–
Id4) were cloned and localized in early chick embryos
(Martinsen and Bronner-Fraser, 1998; Kee and Bronner-Fraser,
2001a,b,c). Our present work with stage-24 chick cardiac
cushion mesenchymal cells revealed that Id1 and Twist
expression was induced by BMP-2 in post-EMT cushion
mesenchymal cells. Because Id1 regulates embryonic vascular
endothelial cell migration (Valdimarsdottir et al., 2002), it will
be of interest to learn interactions between BMP signaling and
these transcription factors and roles of their signaling pathways
in cushion mesenchymal cells during post-EMT valvulogenesis.
In conclusion, our current work provides strong evidence
that BMP-2 and BMP signaling regulate cushion mesenchymal
cell migration and expression of a valvulogenic ECM protein,
periostin, indicating that BMP-2 and BMP signaling play a
critical role in post-EMT AV cushion mesenchyme differentia-
tion and maturation. Because many molecules are known to be
expressed in the post-EMT cushion mesenchyme and involved
in valvulogenesis (Reviews, Armstrong and Bischoff, 2004;
Schroeder et al., 2003; Person et al., 2005; Lincoln et al.,2006b), further studies are warranted to better characterize the
interaction of BMPs and/or BMP signaling with other
valvulogenic regulatory molecules and their molecular cascades
in post-EMT valvulogenesis.
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